Roundup lawsuit latest news 2025: Shocking Verdicts

Why Staying Informed About Roundup Legal Developments Matters

Roundup lawsuit latest news continues to dominate headlines as Bayer faces mounting legal pressure, with thousands of federal cases still pending and billions paid in settlements. If you or a loved one developed cancer like non-Hodgkin lymphoma after using Roundup, understanding the current state of litigation is crucial for your ability to seek compensation.

Key Updates on Roundup Lawsuits (December 2025):

• Over $11 billion paid in settlements to resolve approximately 100,000 claims
• $8+ billion awarded in trial verdicts by juries across multiple states
• 4,508 cases remain pending in federal multidistrict litigation (MDL 2741)
• Recent major verdicts: $2.1 billion in Georgia, $611 million in Missouri (upheld on appeal)
• Bayer has set aside an additional $1.37 billion for future litigation costs
• New lawsuits continue to be filed as more people are diagnosed with cancer
• Statute of limitations varies by state—typically 1-3 years from diagnosis

The legal landscape has evolved dramatically since the first jury verdict in 2018 found that Monsanto's weed killer caused cancer. Since acquiring Monsanto, Bayer has faced an avalanche of litigation from plaintiffs alleging the company knew of glyphosate's cancer risks but failed to warn consumers.

The financial and reputational toll has been severe. Bayer's stock has fallen over 70% since the acquisition, and the company faces new trials with massive jury verdicts. Despite settling most claims, thousands of lawsuits remain active, and new cases are filed as more people are diagnosed with related cancers.

What makes these lawsuits particularly compelling is the emergence of internal "Monsanto Papers." Plaintiffs' attorneys argue these documents show deliberate efforts to influence scientific studies and downplay health risks. These revelations have fueled jury anger, leading to substantial punitive damage awards designed to punish corporate misconduct.

For individuals who used Roundup extensively and later developed cancer, the legal window to seek compensation may be closing. Each state has its own statute of limitations, and understanding where your case stands is critical.

I'm Tim Burd, founder of Justice Hero. We've helped thousands of people connect with qualified attorneys for mass tort claims, including those involving roundup lawsuit latest news developments. My team and I are committed to making complex legal information accessible so you can make informed decisions about your health and legal rights.

Quick look at legal assistance needed and roundup lawsuit claim.

Roundup Lawsuit Latest News: Key Verdicts and Appeals (2024-2025)

The Roundup litigation landscape is constantly shifting with new verdicts, appeals, and strategic moves by Bayer. The roundup lawsuit latest news reveals a company under immense pressure, managing the fallout from its Monsanto acquisition and the associated Roundup liability.

Bayer's legal strategy involves appealing large verdicts, arguing federal preemption (that federal labeling laws should override state-level failure-to-warn claims), and lobbying for legislative action. Despite these efforts, juries continue to find against the company, resulting in significant financial penalties.

Recent Multi-Million and Billion-Dollar Verdicts

Recent years have seen staggering verdicts against Bayer/Monsanto, reflecting jury concern over Roundup's safety and the company's conduct.

• McKivison Verdict ($2.25B reduced to $400M): In January 2024, a Pennsylvania jury awarded $2.25 billion to John McKivison, who developed non-Hodgkin lymphoma after two decades of Roundup use. A court later reduced the award to $400 million in June 2024, but it remains a monumental verdict signaling strong jury sentiment.
• Missouri Verdict ($1.56B reduced to $611M): In November 2023, a Missouri jury awarded $1.56 billion to four plaintiffs. A judge later reduced this to $611 million in April 2024. The Missouri Supreme Court let the $611 million verdict stand in October 2025, representing a massive win for the plaintiffs.
• Philadelphia Verdicts: Philadelphia is a hotbed for Roundup trials. In October 2024, a jury awarded $78 million to William Melissen for his non-Hodgkin lymphoma. However, Monsanto won the Judith Womack case in November 2024, with the jury citing insufficient evidence.
• Georgia Verdict ($2.1B): In March 2025, a Georgia jury awarded John Barnes nearly $2.1 billion. This included $65 million in compensatory damages and $2 billion in punitive damages, highlighting the jury's belief in corporate misconduct.
• California Verdicts: California has also seen landmark verdicts. Dewayne Johnson was awarded $289 million in the first trial in 2018 (later reduced but upheld). In May 2019, a jury awarded over $2 billion to the Pilliods, a couple who both developed non-Hodgkin lymphoma. Another California court upheld a $28 million verdict that could potentially go to the U.S. Supreme Court.

These verdicts, both within California and nationwide, underscore the serious legal challenges Bayer faces. You can find more detailed updates on these cases and others at our Latest Roundup Lawsuit Update page.

Bayer's Response: Appeals and Legislative Action

Bayer's strategy to combat lawsuits is multi-pronged. They consistently appeal adverse verdicts. A key appeals argument is federal preemption: that EPA label approval should prevent state-level failure-to-warn lawsuits. This has met with mixed success. The Ninth Circuit (covering California) rejected the argument, but the Third Circuit accepted it, creating a "circuit split" that might prompt the U.S. Supreme Court to weigh in.

Bayer has petitioned the Supreme Court on preemption. The Biden administration, when asked for its view, recommended against hearing the appeal, stating EPA approval does not necessarily preempt state-law warnings—a significant blow to Bayer's strategy.

Beyond the courts, Bayer is also lobbying for state laws to shield manufacturers from liability if labels comply with federal rules. North Dakota passed such a bill in 2025, with similar efforts reported in Iowa. These actions highlight Bayer's determination to limit its legal exposure.

Bayer is also reportedly exploring Monsanto bankruptcy. Filing Chapter 11 for its Monsanto unit could pause lawsuits and create a path to settle Roundup-related liability in bankruptcy court, signifying the immense financial strain on the company. Bayer has consistently set aside funds for these lawsuits, adding another $1.37 billion to its Roundup litigation reserves in July 2025, bringing its total provisions to billions. You can read more about Bayer's financial provisions here: Bayer has set aside another $1.1 billion to fund Roundup litigation.

Current State of Pending Lawsuits

Despite settlements and appeals, thousands of lawsuits against Bayer/Monsanto continue. As of December 2025, 4,508 open Roundup cases remain in the federal MDL in California. This multidistrict litigation (MDL 2741), overseen by Judge Vince Chhabria in the U.S. District Court for the Northern District of California, consolidates lawsuits to streamline pretrial proceedings.

While the federal MDL in California has seen its share of resolutions, new lawsuit filings continue to trickle in. Our team at Justice Hero keeps a close eye on the Roundup Lawsuit Status to provide the most up-to-date information.

The Science and Controversy: Does Roundup Cause Cancer?

At the heart of every Roundup lawsuit is whether glyphosate, its active ingredient, causes cancer. The divided scientific community has fueled these legal battles. Our Roundup Cancer Link page explores this in depth.

Cancers Linked to Roundup Exposure

The primary cancer linked to Roundup in lawsuits is non-Hodgkin lymphoma (NHL), which originates in the body's lymphatic system. Specific NHL subtypes and related conditions are also frequently cited, including:

• Diffuse Large B-cell Lymphoma (DLBCL): The most common form of NHL, an aggressive cancer affecting B-lymphocytes.
• Chronic Lymphocytic Leukemia (CLL): A type of blood and bone marrow cancer that can also manifest as small lymphocytic lymphoma (SLL), a form of NHL.
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Burkitt Lymphoma
• T-cell Lymphoma
• Hairy Cell Leukemia
• Multiple Myeloma (though less frequently cited than NHL)

An analysis from the University of Washington found that glyphosate increases the risk of non-Hodgkin lymphoma by 41%. For a comprehensive list and detailed explanations, visit our page on What Cancers Are Included in the Roundup Lawsuit.

The Scientific Debate: IARC vs. EPA

The controversy over glyphosate's carcinogenicity stems from differing opinions among major health and regulatory agencies.

• World Health Organization (IARC): In 2015, the International Agency for Research on Cancer (IARC), a division of the World Health Organization, classified glyphosate as "probably carcinogenic to humans." This classification was a significant turning point, sparking many of the lawsuits we see today.
• Environmental Protection Agency (EPA): In contrast, the U.S. Environmental Protection Agency (EPA) has maintained that glyphosate is "unlikely to cause cancer in humans." However, the EPA withdrew this finding in 2022 after the 9th Circuit Court of Appeals overturned its stance.

This scientific disagreement is a central battleground. Plaintiffs cite studies like the meta-analysis in Mutation Research showing a 41% increased risk of non-Hodgkin lymphoma in highly exposed agricultural workers. Bayer cites regulatory approvals and other studies to defend its product. We dig deeper into this complex issue on our Can Roundup Cause Cancer page.

The "Monsanto Papers" and Allegations of Deception

The "Monsanto Papers"—internal documents unearthed during legal findy—have swayed juries and fueled public outrage. Plaintiffs' attorneys claim they reveal a concerted effort by Monsanto to manipulate scientific opinion and influence regulators.

Allegations include:

• Ghostwriting Scientific Studies: Internal emails suggest Monsanto employees ghostwrote scientific articles published under the names of independent scientists. An article in The International Journal of Risk and Safety in Medicine highlighted these revelations, including "Monsanto-sponsored ghostwriting of articles..., interference in the peer review process, [and] behind-the-scenes influence..."
• Influencing Regulators: The papers allegedly show attempts to undermine IARC findings and influence the EPA's assessment.
• Failure to Warn Consumers: Plaintiffs argue these communications show Monsanto knew of potential health risks but deliberately concealed them and failed to warn consumers.

These revelations have painted a picture of corporate misconduct that resonates strongly with juries, leading to significant punitive damages. Our guide, Monsanto vs. The Public: A Guide to All Lawsuits Filed Against Monsanto, explores this history of litigation.

Current Status of Roundup Litigation: Settlements and Payouts

The volume of Roundup lawsuits has created a complex system of settlements and ongoing litigation. To date, Bayer has paid nearly $11 billion in settlements to resolve about 100,000 claims. While this brought closure to many, thousands of cases are still pending, making it key to understand how they are managed and what potential payouts look like. You can learn more about payouts on our Roundup Settlement Payments page.

Understanding the Legal Framework: MDL vs. Class Action

When thousands of similar lawsuits are filed, the legal system employs mechanisms to manage them efficiently.

• Multidistrict Litigation (MDL): The vast majority of federal Roundup lawsuits are consolidated under MDL 2741 in the U.S. District Court for the Northern District of California. Unlike a class action, an MDL groups individual lawsuits with similar claims before one judge for consolidated pretrial proceedings. This allows for efficient findy and rulings on common legal issues. Unsettled cases can be sent back to their original courts for trial. This structure allows for both individual and group settlements, with cases evaluated on their unique merits.
• Class Action: A class action involves a single lawsuit filed on behalf of an entire "class," with any settlement applying to everyone. While a class action was proposed for Roundup purchasers seeking refunds, the primary cancer lawsuits are handled through MDLs or individual state court actions.

For more details on these distinctions, see our Roundup Class Action Lawsuit Update.

Roundup Lawsuit Latest News on Settlement Amounts

The financial compensation for Roundup lawsuits can vary significantly depending on the specifics of each case.

• Settlement Ranges: While the average 2020 settlement was about $105,000 per plaintiff, individual payouts range from $5,000 to over $250,000, reflecting the diverse circumstances of each case.
• Factors Affecting Payouts: Several factors influence the potential compensation, including:
  • Severity of Illness: The type and stage of cancer, its impact on your health, and your prognosis.
  • Duration and Intensity of Exposure: How long and how frequently you used Roundup, and whether your exposure was occupational (e.g., as a farmer or landscaper) or residential.
  • Medical Expenses and Lost Wages: The financial burden incurred due to treatment and inability to work.
  • Age and Dependents: The impact on your quality of life and financial responsibilities.
• Settlement Points System: In large-scale settlements, a "points system" is often used. Points are allocated based on factors like exposure type and duration, illness severity, health at diagnosis, and treatments received. Claims with more points generally receive higher compensation.

To get a clearer picture of what your case might be worth, check out our What is the Average Payout for Roundup Lawsuit guide.

Bayer's Financial Provisions and Stock Impact

The ongoing litigation has had a profound impact on Bayer's finances and market standing.

• Billions in Litigation Reserves: Bayer has repeatedly set aside substantial funds to cover litigation costs. As of December 2025, Bayer has set aside another $1.37 billion to add to its Roundup litigation reserves. The company has already paid out nearly $11 billion in settlements.
• Stock Value Decline Since Monsanto Acquisition: Bayer's $63 billion acquisition of Monsanto in 2018 has been a heavy burden due to legal challenges. The company's stock value has dropped more than 70% since the acquisition, reflecting investor concern. In November 2025, Bayer lowered its expected earnings by about $4 billion due to costs from Roundup lawsuits.
• Financial Pressure from Verdicts: Large jury verdicts, especially those with significant punitive damages, exert immense financial pressure on Bayer. This forces them to re-evaluate legal strategies and settlement offers and is a key driver in efforts to resolve remaining cases.

Stay updated on the financial side of the litigation at our Latest News on Roundup Settlement page.

Do You Qualify for a Roundup Lawsuit? Eligibility and How to File

If you were diagnosed with non-Hodgkin lymphoma or a related cancer after significant Roundup use, you might qualify for a lawsuit. The process can seem daunting, but understanding the eligibility criteria is the first step. Our How to Join Roundup Lawsuit guide is a great place to start.

Key Eligibility Criteria for Filing a Claim

To be eligible for a Roundup lawsuit, several key factors are typically considered:

• Significant Roundup Exposure: You must have a history of regular and prolonged exposure to Roundup. This can be:
  • Occupational: If you used Roundup frequently as part of your job (e.g., farmer, landscaper, groundskeeper, nursery worker).
  • Residential: If you used Roundup regularly for personal lawn and garden care around your home. Generally, lawyers look for at least two years and 50 hours of lifetime exposure.
• Qualifying Cancer Diagnosis: You must have been diagnosed with non-Hodgkin lymphoma or one of its related subtypes (as listed in the previous section).
• "Findy Rule" and State-Specific Deadlines: This is where the statute of limitations comes into play. Each state has specific filing deadlines. However, many states follow a "findy rule," meaning the clock starts when you finded (or reasonably should have finded) the link between your illness and Roundup. Since cancers can take years to develop, this rule is crucial. It is imperative to consult an attorney as soon as possible to determine the specific deadlines for your case.

Our Roundup Lawsuit Claim Complete Guide provides more detailed information on these criteria.

Roundup Lawsuit Latest News on Evidence Requirements

A strong Roundup lawsuit requires compelling evidence of both your exposure and your diagnosis.

• Medical Records: These are paramount. You'll need records confirming your diagnosis of non-Hodgkin lymphoma (or a related cancer), details of your treatment, and the prognosis. This includes diagnosis reports, medical notes, treatment plans, and documents detailing the severity of your illness.
• Proof of Roundup Use: This can be tricky, especially for long-term residential users. Useful evidence includes:
  • Receipts or purchase records of Roundup products.
  • Photos or videos of you using Roundup or the products themselves.
  • Product containers (even old ones, if you still have them).
  • Property records or testimony indicating Roundup use on your land.
  • Yard work notes or diaries.
• Employment Records (for occupational exposure): If your exposure was work-related, documentation like pesticide use records, training certificates, work orders, pesticide licenses, and statements from coworkers can be invaluable.
• Witness Testimony: Accounts from family, friends, or colleagues who observed your Roundup use can also strengthen your claim.

Gathering this evidence is a significant undertaking, which is why legal assistance is so valuable. Our guide on How to Gather Evidence for Your Roundup Cancer Lawsuit offers practical tips.

How a Lawyer Can Help Your Case

Navigating a complex mass tort like the Roundup litigation requires an experienced attorney, who can be your most important ally:

• Free Case Evaluation: Most attorneys, including our partners at Justice Hero, offer a free, no-obligation consultation to assess your eligibility and claim strength.
• Evidence Collection: Lawyers help identify, gather, and organize necessary evidence, often using resources to obtain records you might not easily access.
• Navigating the MDL Process: They understand the intricacies of the federal MDL in California, ensuring your case is properly filed and managed within this complex system.
• Negotiating Settlements: Attorneys are skilled negotiators who can advocate for the maximum possible compensation on your behalf, whether through individual settlements or participation in larger settlement programs.
• Representing You in Court: If your case proceeds to trial, your lawyer will represent your interests, presenting your evidence and arguments to a jury.

Finding the right legal representation is crucial for your success. Visit our Best Lawyer for Roundup Lawsuit page to learn more.

Frequently Asked Questions about Roundup Lawsuits

Is it too late to file a Roundup lawsuit?

While many cases have settled, it is generally not too late to file a Roundup lawsuit, especially with a recent diagnosis. However, this depends on your state's statute of limitations. The "findy rule" can extend these deadlines, but some are as short as one year from diagnosis, so acting quickly is essential. We strongly advise contacting an attorney immediately to determine your specific deadline.

What is the average payout for a Roundup lawsuit?

The average payout from the major 2020 settlement was around $105,000 to $150,000. However, it is important to distinguish between global settlement averages and individual trial verdicts. As recent multi-million and billion-dollar verdicts show, individual trials can result in much higher compensation, especially for severe cases with clear evidence. Your specific payout will depend on the unique factors of your case, such as illness severity, exposure history, and financial impact.

Is Roundup containing glyphosate still sold in the U.S.?

Yes, but with a key distinction. In response to lawsuits and public concern, Bayer stopped selling glyphosate-based Roundup for residential use in 2023. These products now use different active ingredients. However, commercial formulations with glyphosate are still widely available for agricultural use, especially with genetically modified crops. While you may not find it for home use, it remains prevalent in the agricultural industry.

Take Action: Understanding Your Legal Options

The roundup lawsuit latest news shows the fight for justice against Bayer/Monsanto is far from over. With thousands of cases pending, new verdicts emerging, and Bayer allocating billions for litigation, the opportunity to seek compensation for Roundup-related cancers remains.

At Justice Hero, we understand the profound impact a cancer diagnosis has on your life and family. Our mission is to simplify complex legal topics and connect you with qualified attorneys who can champion your cause. We believe in holding corporations accountable and ensuring victims receive the compensation they deserve.

If you or a loved one has been diagnosed with cancer after exposure to Roundup, it's crucial to understand your legal rights. Explore your options and see if you qualify for a Roundup Lawsuit today. Our team is here to guide you through this process and help you find the justice you seek.